English
English
/
中文
HOME
Home
WHO WE ARE
Nav
WHAT WE DO
Nav
INVESTORS
Nav
PIPELINE
Nav
NEWS
Nav
CAREERS
Nav
CONTACT US
Nav
HISTORY
LEADERSHIP
ADVISORS
BOARD OF DIRECTORS
Wang Chunbo , Ph.D - Business Advisor
[ ADVISOR ]
2020-04-16
Timothy P.Coogan,PhD,DABT
[ ADVISOR ]
2020-04-16
David Brooks, PhD,FAHA
[ ADVISOR ]
2020-04-16
Mark Winnett
[ ADVISOR ]
2020-04-16
QA (analysis-oriented)
[ careers ]
2020-04-14
Medicine Director
[ careers ]
2020-04-14
Bio-pharmaceutical Process Director
[ careers ]
2020-04-14
Pharmaceutical Analysis Director
[ careers ]
2020-04-14
Pharmacology/Pharmacodynamics Director
[ careers ]
2020-04-14
Toxicology Director
2020-04-14
DMPK Director
[ careers ]
2020-04-14
"Innovate together to win the future" Fontacea successfully held the launch ceremony in Shenzhen
[ news ]
2020-04-12
A comprehensive cooperation agreement has reached between Fontacea and Wuxi Biologics
2020-04-10
Mr Yanliang Chu, chairman of Fontacea, signed Dr David Brooks as business consultant in USA
[ news ]
2020-02-10
Mr Yanliang Chu, Chairman of Fontacea, signed Dr Timothy P. Coogan as the Medicine Safety Consultant
[ news ]
2019-12-23
Senior leaders attended "Innovative Medicine Investment Seminar"
[ news ]
2019-12-11
Shandong Fontacea is licensed for anti-IL17A monoclonal antibody from Janssen
[ news ]
2019-09-10
Yanliang Chu, welcomes Mark Winnett as Management Consultant to Fontacea
[ news ]
2019-08-12
Fontacea shareholder Lei Meng, chairman of Shandong development investment holding group co. LTD
[ news ]
2019-07-17
to the end ~
